Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Interim Financial .... Interim MD&A .... Reporting

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Interim Financial .... Interim MD&A .... Reporting

KOO-KOO2

Apr 05, 2024 05:49PM

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Interim Financial .... Interim MD&A .... Reporting

in response to

Interim Financial .... Interim MD&A .... Reporting

KOO-KOO2

posted on Apr 07, 2024 04:23PM

I was expecting numbers up to the end of the the 1st quarter 2024/End of March 2024 - these are up to the end of Jan 2024, is that correct?

Re: Interim Financial .... Interim MD&A .... Reporting

chicagoest

Apr 07, 2024 11:51PM

Re: Interim Financial .... Interim MD&A .... Reporting

fuzzyjr

Apr 08, 2024 08:14AM

Reply New Message

Back To Forum List View

Please to post a reply